Norepinephrine metabolism and drugs used in the affective disorders: a possible mechanism of action.
D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D001714:Bipolar Disorder / Q000188:drug therapy; D001921:Brain / Q000378:metabolism*; D000697:Central Nervous System Stimulants / Q000494:pharmacology*; D002746:Chlorpromazine / Q000494:pharmacology; D003042:Cocaine / Q000494:pharmacology; D003863:Depression / Q000188:drug therapy; D003891:Desipramine / Q000494:pharmacology; D004644:Emotions / Q000187:drug effects*; D006801:Humans; D007099:Imipramine / Q000494:pharmacology; D008094:Lithium / Q000494:pharmacology; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism*; D009647:Normetanephrine / Q000378:metabolism; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D014149:Tranquilizing Agents / Q000494:pharmacology*; D014316:Tritium
D000928:Antidepressive Agents; D000697:Central Nervous System Stimulants; D008996:Monoamine Oxidase Inhibitors; D014149:Tranquilizing Agents; D009647:Normetanephrine; D014316:Tritium; D012110:Reserpine; D008094:Lithium; D003042:Cocaine; D007099:Imipramine; D003891:Desipramine; D002746:Chlorpromazine; D009638:Norepinephrine